Liquid-Liquid Phase Separation in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities
Oncology Research · 2026 · 34 (6) · 1-10
DOI: 10.32604/or.2026.076499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2026. Verfasst von Yiyang Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Antineoplastic Agents, Biomolecular Condensates. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW, Australia.
- The Second Clinical Medical College of Guizhou University of Traditional Chinese Medicine, Guizhou, China.
Zitieren
APA
Zhao, Y., Sun, C., Dong, Q., He, J., Wang, Y., & Bi, L. (2026). Liquid-Liquid Phase Separation in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.076499
Vancouver
Zhao Y, Sun C, Dong Q, He J, Wang Y, Bi L. Liquid-Liquid Phase Separation in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.076499
BibTeX
@article{Zhao2026,
author = {Zhao, Yiyang and Sun, Changchang and Dong, Qihan and He, Jiangyang and Wang, Yan and Bi, Ling},
title = {Liquid-Liquid Phase Separation in Cancer Drug Resistance: Mechanisms and Therapeutic Opportunities},
journal = {Oncology Research},
year = {2026},
volume = {34},
number = {6},
pages = {1--10},
doi = {10.32604/or.2026.076499}
}
EUVIMED